We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.69%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$596M
| $19.6K | 0.01% |
200
| – | – |
2022 Q4
14 quarters
|
|
252
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.66B
| $19.5K | 0.01% |
190
| – | – |
2024 Q1
9 quarters
|
|
253
United Parcel Service
UPS
$92.2B
| $19.5K | 0.01% |
181
+60
| +50% | +$6.24K |
2019 Q4
26 quarters
|
|
254
iShares Core High Dividend ETF
HDV
$15.9B
| $19.3K | 0.01% |
+705
| New | +$19.2K |
2026 Q2
0 quarters
|
|
255
Snowflake
SNOW
$97.3B
| $19.1K | 0.01% |
75
| – | – |
2021 Q2
20 quarters
|
|
256
Vanguard Russell 2000 ETF
VTWO
$16.3B
| $19K | 0.01% |
157
| – | – |
2021 Q1
21 quarters
|
|
257
Mirum Pharmaceuticals
MIRM
$6.12B
| $18.7K | 0.01% |
160
| – | – |
2022 Q2
16 quarters
|
|
258
VanEck Agribusiness ETF
MOO
$1.1B
| $18.3K | 0.01% |
232
| – | – |
2019 Q4
26 quarters
|
|
259
Fidelity MSCI Utilities Index ETF
FUTY
$2.06B
| $18.2K | 0.01% |
312
+1
| +0.3% | +$59 |
2024 Q3
7 quarters
|
|
260
Vanguard Total World Stock ETF
VT
$78.7B
| $17.8K | 0.01% |
113
| – | – |
2025 Q4
2 quarters
|
|
261
Arm
ARM
$187B
| $17.7K | 0.01% |
+50
| New | +$13.3K |
2026 Q2
0 quarters
|
|
262
Glaukos
GKOS
$13.3B
| $17.5K | 0.01% |
125
| – | – |
2022 Q2
16 quarters
|
|
263
iShares US Oil & Gas Exploration & Production ETF
IEO
$804M
| $17.4K | 0.01% |
159
+1
| +0.6% | +$116 |
2020 Q2
24 quarters
|
|
264
Veralto
VLTO
$28.5B
| $16.7K | 0.01% |
188
| – | – |
2023 Q4
10 quarters
|
|
265
FS Specialty Lending Fund
FSSL
$903M
| $16.6K | 0.01% |
1,485
+52
| +4% | +$614 |
2025 Q4
2 quarters
|
|
266
Rackspace Technology
RXT
$645M
| $16.3K | 0.01% |
+2,500
| New | +$9.7K |
2026 Q2
0 quarters
|
|
267
VanEck Biotech ETF
BBH
$516M
| $16.3K | 0.01% |
80
| – | – |
2022 Q1
17 quarters
|
|
268
AbbVie
ABBV
$515B
| $16.1K | 0.01% |
64
+32
| +100% | +$6.88K |
2021 Q1
21 quarters
|
|
269
State Street SPDR S&P Regional Banking ETF
KRE
$3.93B
| $15.9K | 0.01% |
212
+1
| +0.5% | +$70 |
2024 Q2
8 quarters
|
|
270
Independent Bank
INDB
$3.94B
| $15.8K | 0.01% |
188
+1
| +0.5% | +$79 |
2024 Q3
7 quarters
|
|
271
CVRx
CVRX
$23.1M
| $15.4K | 0.01% |
3,000
| – | – |
2024 Q3
7 quarters
|
|
272
Eaton
ETN
$133B
| $15.3K | 0.01% |
36
+10
| +38% | +$4.03K |
2019 Q4
26 quarters
|
|
273
Williams Companies
WMB
$80.1B
| $15.2K | 0.01% |
205
-43
| -17% | -$3.16K |
2025 Q1
5 quarters
|
|
274
iShares Russell 1000 Value ETF
IWD
$82.7B
| $15.1K | 0.01% |
62
| – | – |
2025 Q2
4 quarters
|
|
275
Fidelity MSCI Energy Index ETF
FENY
$2.08B
| $14.8K | 0.01% |
500
| – | – |
2024 Q2
8 quarters
|
|
Similar funds
BOC
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.